AdBio partners (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:Paris

AdBio partners is a venture capital fund supported in particular by the National Seed-Fund from France, with a focus on early-stage startups in life sciences in Europe.

Average round investment:32.94M USD
Average number per year:2.2
Distribution: 2026 (1)2025 (5)2024 (2)2023 (6)2022 (1) See the entire list
Mostly invests in: Belgium Belgium (6) Biotech (18)
See the entire list

Showing 3 of 18 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

AdBio partners mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to AdBio partners

Name Criteria
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, United Kingdom, Switzerland, Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium Vives Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, France, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Belgium Korys
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Denmark
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United States Kindred Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, United Kingdom, Switzerland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, Switzerland, Denmark
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
United Kingdom Ahren Innovation Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Belgium V-Bio Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, France, United Kingdom, Denmark
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Belgium Bioqube Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Belgium, France, United Kingdom, Denmark
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Germany SevenVentures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland, Denmark
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Germany Yabeo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Spain, United Kingdom
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top